Assessment of the psycho-emotional state of patients after COVID-19-associated pneumonia in relationship with laboratory indicators

The aim. To study peculiarities and association of psychological and laboratory indicators in patients with cardiovascular diseases (CVD) who underwent COVID-19 to clarify the factors affecting the possibility of developing delayed psychological and cardiovascular adverse events.

Methods. The study enrolled 350 patients with COVID-19. Group 1 consisted of 92 patients without CVD, Group 2 – of 258 patients with CVD. Indicators of laboratory and psychological parameters were assessed according to the data of psychological questionnaire using GAD-7 (General Anxiety Disorder-7), PHQ-9 (Patient Health Questionnaire-9), PSS (Perceived Stress Scale) screening scales and SF-36. Parameters of complete blood count and biochemical blood tests were measured during hospitalization and three months after discharge from the monohospital.

Results. After three months, in the general group of patients, signs of anxiety and depression were detected in more than 30 % of the examined patients, signs of stress – in 10.4 %. In the group with CVD, psycho-emotional disorders were identified in 1/4 of the patients, and severe stress – in 8 % of those included in the study. In addition, it was registered that the indicators of erythrocyte sedimentation rate, fibrinogen, high-sensitivity C-reactive protein (CRP), homocysteine and IL-6 remained at a higher level in the second group.

Correlation analysis showed that the psychological component of health is interconnected with the level of neutrophils (p = 0.044) and fibrinogen (p = 0.050); the physical component of health is correlated with the level of erythrocytes (p = 0.030), hemoglobin (p = 0.015), CRP (p = 0.002), creatine phosphokinase (p = 0.036) and glucose (p = 0.017). Regression analysis revealed that in patients with CVD three months after hospitalization, an increased glucose index contributes to deterioration, and increased hematocrit and mean hemoglobin concentration improve the quality of life of patients.

Conclusion. Laboratory markers that maintain the duration of a prolonged vascular reaction, violation of the rheological and metabolic properties of blood, determine the nature of the development of both psychological and cardiovascular complications.

1. Kostina OV, Galova EA, Lyubavina NA, Presnyakova MV, Vedunova MV. Characterization of changes in biochemical parameters during dynamic observation in patients with COVID-19 and in the post-COVID period. Profilakticheskaya meditsina. 2022; 25(5): 86-92. (In Russ.). doi: 10.17116/profmed20222505186

2. Kirilenko NP, Ilyina NN. COVID-19 and cardiovascular disease: Cardiovascular comorbidity, incidence of COVID-19, severity and post-covid syndrome. Profilakticheskaya meditsina. 2022; 25(5): 79-85. (In Russ.). doi: 10.17116/profmed20222505179

3. Chazova IE, Mironova OYu. COVID-19 and cardiovascular diseases. Terapevticheskii arkhiv. 2020; 92(9): 4-7. (In Russ.). doi: 10.26442/00403660.2020.09.000742

4. Buryachkovskaya LI, Melkumyants AM, Lomakin NV, Antonova OA, Ermishkin VV. Damage to the vascular endothelium and erythrocytes in patients with COVID-19. Consilium medicum. 2021; 23(6): 469-476. (In Russ.). doi: 10.26442/20751753.2021.6. 200939

5. Tyapaeva AR, Semenova ON, Tashkenbaeva EN, Nasyrova ZA, Naumova EA. Clinical and laboratory manifestations and psychological features of COVID-19 in patients with cardiovascular diseases and moderate severity of coronavirus infection one month after discharge from the hospital. Russian Journal of Cardiology. 2021; 26(4S): 4603. (In Russ.). doi: 10.15829/1560-4071-2021-4603

6. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. COVID-19 and cardiovascular disease. Circulation. 2020; 141(20): 1648-1655. doi: 10.1161/CIRCULATIONAHA.120.046941

7. Piticchio T, Moli R, Tumino D, Frasca E. Relationship between betacoronsviruses and the endocrine system: A new key to understand the COVID-19 pandemic – A comprehensive review. J Endocrinol Invest. 2021; 44(8): 1553-1570. doi: 10.1007/s40618-020-01486-0

8. Ababkov VA, Baryshnikova K, Vorontsova-Venger OV, Gorbunov IA, Kapranova SV, Pologaeva EA, et al. Validation of the Russian version of the questionnaire “Scale of perceived stress-10”. Vestnik of Saint Petersburg University. Psychology. 2016; 2: 6-15. (In Russ.). doi: 10.21638/11701/spbu16.2016.202

9. Instruction manual. Instructions for Patient Health Questionnaire (PHQ) and GAD-7 Measures. London: Pfizer; 2021. URL: https://www.phqscreeners.com/images/sites/g/ files/g10016261/f/201412/instructions.pdf [date of access: 15.01.2021].

10. Novik AA, Ionova TI. Guidelines for the study of quality of life in medicine; 2nd ed. Moscow; 2007. (In Russ.).

11. Ansovini R, Compagnucci L. The hypothetical role of erythrocytes in COVID-19: Immediate clinical therapy. J Biomed Res Environ Sci. 2020; 1(3): 048-050. doi: 10.37871/jels1119

12. Lu G, Wang J. Dynamic changes in routine blood parameters of a severe COVID-19 case. Clin Chim Acta. 2020; 508: 98-102. doi: 10.1016/j.cca.2020.04.034

13. Vafadar Moradi E, Teimouri A, Rezaee R, Morovatdar N, Foroughia M, Layegh P, et al. Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality. AmJ Emerg Med. 2021; 40: 11-14. doi: 10.1016/j.ajem.2020.12.003

14. Zhou W, Song L, Wang X, Zheng X, Shudong W, Wang J, et al. Cardiac injury prediction and lymphocyte immunity and inflammation analysis in hospitalized patients with coronavirus disease 2019 (COVID-19). Int J Cardiol. 2021; 326: 237-242. doi: 10.1016/j.ijcard.2020.10.049

15. Seyit M, Avci E, Nar R, Senol H, Yilmas A, Ozen M, et al. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Am J Emerg Med. 2021; 40: 110-114. doi: 10.1016/j.ajem.2020.11.058

16. Delshad M, Safaroghli-Azar A, Pourbagheri-Sigaroodi A, Pook B, Shokouhi S, Bashash D, et al. Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity. Int Immunopharmacol. 2021; 99: 107995. doi: 10.1016/j.intimp.2021.107995

17. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 844-847. doi: 10.1111/jth.14768

18. Marcolino MS, Ziegelmann PK, Souza-Silva MVR, Nascimendo ISB, Oliveira LM, Monteiro LS, et al.; Brazilian COVID-19 Registry Investigators. Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: Results from the Brazilian COVID-19 registry. IntJ Infect Dis. 2021; 107: 300-310. doi: 10.1016/j.ijid.2021.01.019

19. Petelina TI, Musikhina NA, Garanina VD, Gorbatenko EA, Shcherbinina AE, Zhmurov DV, et al. Prospective analysis of laboratory blood parameters in patients with cardiovascular diseases who had COVID-19-associated pneumonia. Klinicheskaya laboratornaya diagnostika. 2022; 67(3): 133-139. (In Russ.). doi: 10.51620/0869-2084-2022-67-3-133-139

20. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens S, et al. Post-acute COVID-19 syndrome. Nat Med. 2021; 27(4): 601-615. doi: 10.1038/s41591-021-01283-z

21. Vasilyeva AV. Mental disorders associated with the COVID-19 pandemic (international experience and approaches to therapy). Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2020; 120(9):121- 129. (In Russ.). doi: 10.17116/jnevro2020120091121

22. Dong F, Liu HL, Dai N, Yang M, Liu JP. A living systematic review of the psychological problems in people suffering from COVID-19. J Affect Disord. 2021; 292: 172-188. doi: 10.1016/j.jad.2021.05.060

23. Vyrupaeva EV, Semyonova NV, Rychkova LV, Petrova AG, Darenskaya MA, Kolesnikov SI, et al. Assessment of the general condition and quality of life of women of post-reproductive age who had asymptomatic COVID-19 and 12 months after the moderate form of the disease. Acta biomedica scientifica. 2022; 7(5-1): 77-85. (In Russ.). doi: 10.29413/ABS2022-7.5-1.9

24. Morina N, Kip A, Hoppen TH, Priebe S, Meyer T. Potential impact of physical distancing on physical and mental health: A rapid narrative umbrella review of meta-analyses on the link between social connection and health. BMJ Open. 2021; 11(3): e042335. doi: 10.1136/bmjopen-2020-042335

25. Roy D, Ghosh R, Dubey S, Dubey MJ, Benito-León J, Kanti Ray B. Neurological and neuropsychiatric impacts of COVID-19 pandemic. Can J Neurol Sci. 2021; 48(1): 9-24. doi: 10.1017/cjn.2020.173

26. Drapkina OM, Fedin AI, Dorofeeva OA, Medvedev VE, Kareva EN, Dzhioeva ON, et al. Influence of psychosocial risk factors on the course and prognosis of cardiovascular diseases. Cardiovascular Therapy and Prevention. 2022; 21(5): 3280. (In Russ.). doi: 10.15829/1728-8800-2022-3280.

27. Ramezani M, Simani L, Karimialavijeh E, Rezaei O, Hajiesmaeili H, Pakdaman H. The role of anxiety and cortisol in outcomes of patients with Covid-19. Basic Clin Neurosci. 2020; 11(2): 179-184. doi: 10.32598/bcn.11.covid19.1168.2

28. Ellins EA, Rees DA, Deanfield JE, Steptoe A, Halcox JP. Increased fibrinogen responses to psychophysiological stress predict future endothelial dysfunction implications for cardiovascular disease? Brain Behav Immun. 2017; 60: 233-239. doi: 10.1016/j.bbi.2016.10.017

29. Uysal Aİ, Altıparmak B, Korkmaz Toker M, Dede G, Sezgin Ç, Gümüş Demirbilek S. The effect of preoperative anxiety level on mean platelet volume and propofol consumption. BMC Anesthesiol. 2020; 20(1): 34. doi: 10.1186/s12871-020-0955-8

30. Liu RH, Pan JQ, Tang XE, Li B, Liu SF, Ma WL. The role of immune abnormality in depression and cardiovascular disease. J Geriatr Cardiol. 2017; 14(11): 703-710. doi: 10.11909/j.issn.1671-5411.2017.11.006

31. Lee HS, Park E. Association of serum ferritin level and depression with respect to the body mass index in Korean male adults. Nutr Res Pract. 2019; 13(3): 263-267. doi: 10.4162/nrp.2019.13.3.263

32. Selenius JS, Wasenius NS, Kautiainen H, Salonen M, von Bonsdorff M, Eriksson JG. Impaired glucose regulation, depressive symptoms, and health-related quality of life. BMJ Open Diabetes Res Care. 2020; 8(1): e001568. doi: 10.1136/bmjdrc-2020-001568